Clinical Trial Update: Comparison of VoLumen and Breeza Oral Contrast Agents in Pediatric Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing VoLumen and Breeza oral contrast agents in pediatric patients with inflammatory bowel diseases has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Disease

Drugs mentioned

• Breeza
• VoLumen

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Inflammatory Bowel Diseases | Phase 4 | Status: COMPLETED